The three objectives of the Convention on Biological Diversity (CBD) —conservation of biological diversity; sustainable use of its components; and fair and equitable sharing of benefits from the utilisation of genetic resources—are mutually supportive. Their attainment requires the collaboration of all actors in the conservation and use of genetic resources. The third objective is no exception. To give it effect and to fulfil its important role in encouraging conservation and sustainable use, practical and workable access and benefit-sharing frameworks and a collaborative working relationship between government and business and other users is essential. By working together to build an environment that supports innovation and the creation of societal and other benefits which can then be shared, governments, business and other stakeholders will be able to contribute more effectively to the goals of the CBD and to the UN SDGs. To help advance such collaboration, ICC has developed this booklet to promote a better understanding of what is required to build practical and workable access and benefit sharing (ABS) frameworks that would encourage and support ABS partnerships and sourcing by businesses. The publication addresses the following themes: Business context Incentives for sourcing Legal certainty and predictability Simple, transparent and efficient system Transparency of requirements Other measures facilitating compliance and ABS agreements Mutually agreed terms (MAT)

Private sector (business and industry)

El Protocolo Comunitario Biocultural es un instrumento de planificación y gestión, elaborado por la comunidad, que integra reglas de organización, toma de decisiones, acceso, uso, aprovechamiento, gestión y manejo del conocimiento tradicional asociado a la biodiversidad y sus componentes, dentro de un territorio determinado. Sirve para que quienes quieran hacer uso o aprovechamiento de sus conocimientos tradicionales asociados a los recursos genéticos conozcan las reglas de uso, manejo, conservación y protección acordados por la comunidad. El Protocolo Comunitario Biocultural del Grupo MASAVI (Mano Amiga, Salud y Vida) y la Comunidad de Juan de Herrera representa un hito de gran relevancia para este municipio de Juan de Herrera, y en particular para el Grupo MASAVI. Este Protocolo Comunitario Biocultural (PCB) constituye el primer documento de esta naturaleza que se realiza en la República Dominicana.

In 1993, the Australian State of Queensland's Griffith University formed a partnership with Astra Pharmaecuticals to pursue a natural product (NP) drug discovery programme under the banner of the Queensland Pharmaceutical Research Institute (QPRI). This partnership persisted through the merger of Astra Pharmaceuticals with Zeneca to form AstraZeneca AB in 1999. QPRI was renamed AstraZeneca R&D Brisbane, then evolved into the Natural Product Discovery Unit (NPD), and finally moved under the aegis of the Eskitis Institute for Cell and Molecular Therapies